First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study.
Saved in:
| Title: | First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study. |
|---|---|
| Authors: | Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy., Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain. javier.molinace@gmail.com.; Alcalá University, Madrid, Spain. javier.molinace@gmail.com., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Via Albertoni 15, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Cerbone L; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy., Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Faculty of Medicine in Pilsen, Biomedical Center, Charles University, Pilsen, Czech Republic., Fornarini G; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Monteiro FSM; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Oncology and Hematology Department, Hospital Sirio-Libanês, SGAS 613 Lote 94, Brasília, DF, Brazil., Cattrini C; Department of Medical Oncology, 'Maggiore Della Carità' University Hospital, 28100, Novara, Italy., Landmesser J; Klinik Für Urologie, Ratzeburger Allee 160, 23538, Lübeck, Germany., Messina C; Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy., Zgura A; Department of Oncology-Radiotherapy, Prof. Dr. Alexandru Trestioreanu Institute of Oncology, 'Carol Davila', University of Medicine and Pharmacy, Bucharest, Romania., Rebuzzi SE; Ospedale San Paolo, Medical Oncology, 17100, Savona, Italy.; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy., Soares A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Carrozza F; Department of Medical Oncology, AUSL Della Romagna, Ospedale Civile Degli Infermi, Faenza, Italy., Ansari J; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates., Grillone F; SOC Oncologia PO Pugliese-Ciaccio Azienda Ospedaliera Universitaria Renato Dulbecco, Catanzaro, Italy., Küronya Z; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary., Incorvaia L; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Bhuva D; Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India., Ortega C; Division of Oncology, Institute for Cancer Research and Treatment, Asl Cn2 Alba-Brà, 12051, Alba-Brà, Italy., Nasso C; Medical Oncology, Ospedale Santa Corona, 17027, Pietra Ligure, Italy., Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Zampiva I; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy., Porta C; Interdisciplinary Department of Medicine, University of Bari 'Aldo Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico Di Bari, Piazza Giulio Cesare, 11, 70124, Bari, Italy., Buti S; Medical Oncology Unit, University Hospital of Parma - Department of Medicine and Surgery, University of Parma, Parma, Italy., Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Jan 03; Vol. 74 (2), pp. 65. Date of Electronic Publication: 2025 Jan 03. |
| Publication Type: | Journal Article; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39752009 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Roviello+G%22">Roviello G</searchLink>; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Molina-Cerrillo+J%22">Molina-Cerrillo J</searchLink>; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain. javier.molinace@gmail.com.; Alcalá University, Madrid, Spain. javier.molinace@gmail.com.<br /><searchLink fieldCode="AU" term="%22Massari+F%22">Massari F</searchLink>; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Via Albertoni 15, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Cerbone+L%22">Cerbone L</searchLink>; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Fiala+O%22">Fiala O</searchLink>; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Faculty of Medicine in Pilsen, Biomedical Center, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Fornarini+G%22">Fornarini G</searchLink>; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Monteiro+FSM%22">Monteiro FSM</searchLink>; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Oncology and Hematology Department, Hospital Sirio-Libanês, SGAS 613 Lote 94, Brasília, DF, Brazil.<br /><searchLink fieldCode="AU" term="%22Cattrini+C%22">Cattrini C</searchLink>; Department of Medical Oncology, 'Maggiore Della Carità' University Hospital, 28100, Novara, Italy.<br /><searchLink fieldCode="AU" term="%22Landmesser+J%22">Landmesser J</searchLink>; Klinik Für Urologie, Ratzeburger Allee 160, 23538, Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Messina+C%22">Messina C</searchLink>; Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Zgura+A%22">Zgura A</searchLink>; Department of Oncology-Radiotherapy, Prof. Dr. Alexandru Trestioreanu Institute of Oncology, 'Carol Davila', University of Medicine and Pharmacy, Bucharest, Romania.<br /><searchLink fieldCode="AU" term="%22Rebuzzi+SE%22">Rebuzzi SE</searchLink>; Ospedale San Paolo, Medical Oncology, 17100, Savona, Italy.; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Soares+A%22">Soares A</searchLink>; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.<br /><searchLink fieldCode="AU" term="%22Carrozza+F%22">Carrozza F</searchLink>; Department of Medical Oncology, AUSL Della Romagna, Ospedale Civile Degli Infermi, Faenza, Italy.<br /><searchLink fieldCode="AU" term="%22Ansari+J%22">Ansari J</searchLink>; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Grillone+F%22">Grillone F</searchLink>; SOC Oncologia PO Pugliese-Ciaccio Azienda Ospedaliera Universitaria Renato Dulbecco, Catanzaro, Italy.<br /><searchLink fieldCode="AU" term="%22Küronya+Z%22">Küronya Z</searchLink>; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Incorvaia+L%22">Incorvaia L</searchLink>; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Bhuva+D%22">Bhuva D</searchLink>; Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Ortega+C%22">Ortega C</searchLink>; Division of Oncology, Institute for Cancer Research and Treatment, Asl Cn2 Alba-Brà, 12051, Alba-Brà, Italy.<br /><searchLink fieldCode="AU" term="%22Nasso+C%22">Nasso C</searchLink>; Medical Oncology, Ospedale Santa Corona, 17027, Pietra Ligure, Italy.<br /><searchLink fieldCode="AU" term="%22Kanesvaran+R%22">Kanesvaran R</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Zampiva+I%22">Zampiva I</searchLink>; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy.<br /><searchLink fieldCode="AU" term="%22Porta+C%22">Porta C</searchLink>; Interdisciplinary Department of Medicine, University of Bari 'Aldo Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico Di Bari, Piazza Giulio Cesare, 11, 70124, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Buti+S%22">Buti S</searchLink>; Medical Oncology Unit, University Hospital of Parma - Department of Medicine and Surgery, University of Parma, Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Santoni+M%22">Santoni M</searchLink>; Oncology Unit, Macerata Hospital, Macerata, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2025 Jan 03; Vol. 74 (2), pp. 65. <i>Date of Electronic Publication: </i>2025 Jan 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39752009 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00262-024-03897-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 65 Titles: – TitleFull: First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Roviello G – PersonEntity: Name: NameFull: Molina-Cerrillo J – PersonEntity: Name: NameFull: Massari F – PersonEntity: Name: NameFull: Cerbone L – PersonEntity: Name: NameFull: Fiala O – PersonEntity: Name: NameFull: Fornarini G – PersonEntity: Name: NameFull: Monteiro FSM – PersonEntity: Name: NameFull: Cattrini C – PersonEntity: Name: NameFull: Landmesser J – PersonEntity: Name: NameFull: Messina C – PersonEntity: Name: NameFull: Zgura A – PersonEntity: Name: NameFull: Rebuzzi SE – PersonEntity: Name: NameFull: Soares A – PersonEntity: Name: NameFull: Carrozza F – PersonEntity: Name: NameFull: Ansari J – PersonEntity: Name: NameFull: Grillone F – PersonEntity: Name: NameFull: Küronya Z – PersonEntity: Name: NameFull: Incorvaia L – PersonEntity: Name: NameFull: Bhuva D – PersonEntity: Name: NameFull: Ortega C – PersonEntity: Name: NameFull: Nasso C – PersonEntity: Name: NameFull: Kanesvaran R – PersonEntity: Name: NameFull: Zampiva I – PersonEntity: Name: NameFull: Porta C – PersonEntity: Name: NameFull: Buti S – PersonEntity: Name: NameFull: Santoni M IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 01 Text: 2025 Jan 03 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1432-0851 Numbering: – Type: volume Value: 74 – Type: issue Value: 2 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |
